Mark Holterman, MD, has worked for more than two decades building a career as an accomplished researcher and medical practitioner. Before taking on his current role as professor of surgery and pediatrics at the University of Illinois College of Medicine, Dr. Mark Holterman received the Innovative Research Award from the American Diabetes Association (ADA).
Over the last six decades, ADA has supported nearly 5,000 research initiatives in the field of diabetes through grant funding and dedicated research programming. The Core Research Program is one such avenue through which the organization supports diabetes researchers. In 2017, ADA recognized groundbreaking study in this field with its two Innovative Research Awards.
ADA’s Innovative Basic Science (IBS) Award helps fund work in the field of diabetes etiology and the challenges it poses to treatment efforts. The award gives special consideration to those researchers who are either working on early-stage studies or are poised to make great impact with their work. At the most, the IBS Award provides $115,000 in funding each year for a maximum of three years.
Another Core Program award is the Innovative Clinical or Translational Science (ICTS) Grant, which can supply faculty researchers with up to $200,000 in annual funding over a three-year period. This award focuses primarily on researchers who have applied their medical theories in clinical applications that use humans as research subjects.